Roberta Ceruti

Suggest Changes

Writes About:

Learn More
PURPOSE This study was conducted to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of the i.v. pan-aurora kinase inhibitor PHA-739358, danusertib, in patients with advanced(More)